In this study, we have demonstrated that sinefungin, a specific inhibitor of SET7/9, ameliorates not only peritoneal fibrosis but also peritoneal dysfunction through suppression of H3K4me1 in MGO-injected mice. The gene discussed is SETD7; the disease is Peritoneal Fibrosis.